MedTech Insights: Accelus Secures $20 Million from Symbiotic Capital, Propelling Expansion in Spinal Implant Technology
Accelus, a pioneer in expandable spinal implant technologies, secured a $20 million debt facility from Symbiotic Capital.
Accelus, a pioneer in expandable spinal implant technologies, secured a $20 million debt facility from Symbiotic Capital.
Andy’s fascinating professional journey, beginning in the early 1990s with Danek, through his pivotal role as a co-founder of K2M, to some of his current initiatives with NeuroSpine Ventures, is a narrative of relentless innovation, unwavering dedication, and significant value creation.
JPM 2024 revitalizes MedTech and Biotech, showcasing deals, AI progress, and cross-border collaboration.
Discover how Erez Lampert steers PathKeeper Surgical through adversity with innovation.
Explore the orthopedic sector’s transformation through Laurent Pruvost’s journey from Sofamor to Intech CEO in our revealing interview.
Uncover expert views on 2023’s MedTech funding, exploring challenges, and strategies with David Kereiakes.
Discover the MedTech landscape’s evolution through Globus Medical and NuVasive’s merger, forging innovation and care.
We recently had the chance to speak with Kevin McGann about what makes Accelus unique.